🔴 GH Research is trading 5.5% down today amid a 2.01% XBI session decline

GH Research is trading at $18.91, down 5.54%, with biotech-sector weakness the likeliest available context.

• XBI was down 2.01% during the session, though that does not fully account for GH Research’s larger decline.
• No fresh company-specific negative announcement was identified; its disclosed ECNP presentations were scheduled for October 11, not announced as negative news.
• Shares also fell 5.16% in the prior session. No trading-volume information was provided, so activity level cannot be assessed.